Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
Michelucci A, Margiotta FM, Cartocci A, Panduri S, Trovato E, Calpalbo E, Dragotto M, Di Cesare A, Rosi E, Rossari S, Magnano M, Pescitelli L, Buggiani G, Simoni B, Lorenzoni E, Ricceri F, Savarese I, Milanesi N, Rubegni P, Prignano F, Romanelli M.
Michelucci A, et al. Among authors: pescitelli l.
Arch Dermatol Res. 2024 May 25;316(6):272. doi: 10.1007/s00403-024-03146-2.
Arch Dermatol Res. 2024.
PMID: 38796581